Desktop MRI System Designed for Easy Use, Easy-to-Site Preclinical and Molecular Imaging
By LabMedica International staff writers Posted on 30 Sep 2010 |
Image: The Icon MRI system (photo courtesy Bruker).
A new easy-to-use 1.0 Tesla desktop magnetic resonance imaging (MRI) scanner combines simplicity with compact dimensions brings preclinical MRI scanning within reach for a wider range of molecular imaging laboratories.
Bruker Corp. (Billerica, MA, USA) announced the introduction of the Icon MRI system, with its innovative cryogen-free permanent magnet from Aspect Magnet Technologies (Netanya, Israel) and high-performance Avance III spectrometer technology with industry-leading preclinical MRI software ParaVision from Bruker, the new Icon system delivers powerful performance and ease of use at an attractive price point.
The Icon is a state-of-the-art and cost-effective MRI instrument for routine preclinical and molecular imaging in biomedical and pharmaceutical applications. Bruker's industry standard MRI software ParaVision guarantees access to a wide range of acquisition and processing tools for in vivo and material science MRI applications. Optional software modules enable the Icon to perform the latest MRI applications, such as relaxometry mapping, fast echo-planar imaging, ultra-short echo time lung imaging, or contrast agent research. As an educational tool, students will find the ParaVision software intuitive, whether it is used to perform research-imaging protocols, or to learn programming of MRI methods.
The new compact shielded permanent magnet with its very small footprint results in an easy to site and install MRI system with almost negligible running costs. Even with a field strength of 1 Tesla, the Icon has zero magnetic fringe field enabling safe location of the system in any facility and for use by any operator. No additional magnetic or radiofrequency (RF) shielding is required for the implementation in the lab. Icon benefits from the Avance III sophisticated digital RF architecture as the technologic basis for the latest MRI applications of today's and tomorrow's preclinical questions.
Dr. Wulf I. Jung, managing director of Bruker BioSpin MRI, GmbH, commented, "High-performance desktop MRI systems have the potential to deliver new research applications to the field of preclinical and molecular imaging. The Icon system is aimed at easy, routine MRI workflows with a compact footprint, low running costs, no magnetic stray fields, and push-button imaging performance, based on the latest Bruker spectrometer and software technology, in order to enable new research groups to enter this fascinating field of preclinical and materials MRI.”
Related Links:
Bruker
Aspect Magnet Technologies
Bruker Corp. (Billerica, MA, USA) announced the introduction of the Icon MRI system, with its innovative cryogen-free permanent magnet from Aspect Magnet Technologies (Netanya, Israel) and high-performance Avance III spectrometer technology with industry-leading preclinical MRI software ParaVision from Bruker, the new Icon system delivers powerful performance and ease of use at an attractive price point.
The Icon is a state-of-the-art and cost-effective MRI instrument for routine preclinical and molecular imaging in biomedical and pharmaceutical applications. Bruker's industry standard MRI software ParaVision guarantees access to a wide range of acquisition and processing tools for in vivo and material science MRI applications. Optional software modules enable the Icon to perform the latest MRI applications, such as relaxometry mapping, fast echo-planar imaging, ultra-short echo time lung imaging, or contrast agent research. As an educational tool, students will find the ParaVision software intuitive, whether it is used to perform research-imaging protocols, or to learn programming of MRI methods.
The new compact shielded permanent magnet with its very small footprint results in an easy to site and install MRI system with almost negligible running costs. Even with a field strength of 1 Tesla, the Icon has zero magnetic fringe field enabling safe location of the system in any facility and for use by any operator. No additional magnetic or radiofrequency (RF) shielding is required for the implementation in the lab. Icon benefits from the Avance III sophisticated digital RF architecture as the technologic basis for the latest MRI applications of today's and tomorrow's preclinical questions.
Dr. Wulf I. Jung, managing director of Bruker BioSpin MRI, GmbH, commented, "High-performance desktop MRI systems have the potential to deliver new research applications to the field of preclinical and molecular imaging. The Icon system is aimed at easy, routine MRI workflows with a compact footprint, low running costs, no magnetic stray fields, and push-button imaging performance, based on the latest Bruker spectrometer and software technology, in order to enable new research groups to enter this fascinating field of preclinical and materials MRI.”
Related Links:
Bruker
Aspect Magnet Technologies
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples